Please try another search
Danaher Corporation's (NYSE:DHR) Executive Vice President, Joakim Weidemanis, has sold a significant portion of his holdings in the company. According to a recent filing, Weidemanis disposed of 22,433...
On Wednesday, BofA Securities updated its outlook on Danaher Corporation (NYSE:DHR), a global science and technology innovator. The firm's analyst increased the price target for Danaher to $270 from...
Danaher Corporation's (NYSE:DHR) President and CEO, Blair Rainer, has sold a significant portion of his holdings in the company, according to a recent filing with the Securities and Exchange...
In a recent transaction, Brian W. Ellis, Senior Vice President and General Counsel of Danaher Corp (NYSE:DHR), sold 4,000 shares of the company's common stock. The sale, which took place on April 24,...
On Wednesday, Baird expressed a positive outlook on Danaher Corporation (NYSE: NYSE:DHR), raising the stock's price target to $271 from $259, while reiterating an Outperform rating. The adjustment...
On Wednesday, TD Cowen showed a positive stance on Danaher Corporation's (NYSE:DHR) financial prospects by raising the price target on the company's stock to $290 from the previous $280, while...
Danaher Corporation (NYSE: NYSE:DHR) has reported a strong start to 2024, with first-quarter revenue, earnings, and cash flow surpassing expectations. The company has seen growth in its bioprocessing...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review